Jeffrey E. Perelman Distinguished Chair in Pediatrics
Chief, Division of Pediatric Oncology
Director, Center for Childhood Cancer Research
Children’s Hospital of Philadelphia
Dr. Hunger specializes in research and treatment regarding children, adolescents and young adults with acute lymphoblastic leukemia (ALL). He has authored more than 225 peer-reviewed manuscripts. He was the Vice-Chairman (2002-2007) and Chairman (2008-2015) of the Children’s Oncology Group (COG) ALL Disease Committee. In these roles he has been responsible for oversight of the design and conduct of clinical trials and linked translational research studies that enroll over 2000 children with ALL each year, including more than 70% of US children and adolescents diagnosed with ALL. Dr. Hunger leads the COG ALL TARGET Project, that has conducted comprehensive studies of the genetic features of childhood ALL and revolutionized understanding of the genomic landscape of pediatric ALL. These findings are now being translated to clinical trials of targeted therapy in Philadelphia chromosome-like ALL. Dr. Hunger also has a major interest in global oncology with a focus on improving cure rates for children with ALL in low and middle income countries.
“I like to travel and have had the opportunity to visit countries all over the world for both professional reasons and pleasure”.
“Most of my efforts focus on improving treatment for children with cancer in a major quaternary care center in the United States. Yet most children with cancer live in low and middle income countries and most cancer deaths occur in those counties. The 20th century saw smallpox eradicated, something no one thought could happen, saving hundreds of millions of lives. Hopefully the 21st century will see childhood cancer eradicated”.